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Osteochondroplastic tracheobronchopathy (OT) is a rare benign disorder of the lower part of the 
trachea and the upper part of the main bronchus characterized by numerous submucosal calcified 
nodules, sessile, cartilaginous and/or osseous with laryngotracheobronchial lumen projection. There 
are less than 400 cases reported in the word literature. 
Aim: to report and discuss 02 cases of OT with a bibliography review. 
Materials and Methods: we report on 02 cases with bibliography revision from MEDLINE, LILACS 
and PUBMED data. 
Study design: observational, descriptive, case reports. 
Conclusion: the symptoms result from airway obstruction, causing dry cough, dyspnea and recurrent 
respiratory tract infections. The diagnostic hypothesis is established by endoscopy of the upper 
airway (laryngo-tracheo-bronchoscopy), and the trachea/chest computed tomography is the best 
image exam to define tracheal nodule alterations. The differential diagnoses are papillomatosis, 
amyloidosis and sarcoidosis chondrosarcoma hamartoma and calcified paratracheal lymph nodes. 
There is no specific treatment and the prognosis is good. Surgery is restricted to moderate or severe 
airway obstructions. Otorhinolaryngologists must include OT in the differential diagnosis of cases 
of upper airway and tracheobronchial tree suggestive symptoms.
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INTRODUCTION
Osteochondroplastic tracheobronchopathy (OT) 
is a rare and benign disease, of unknown cause, also 
described as osteoplastic tracheopathy, characterized by 
numerous submucosal sessile nodules, cartilaginous or 
bony, distributed through the antero-lateral walls, pro-
jecting to the laryngotracheobronchial lumen1. The first 
publications concerning OT were made in 1855 by Wilks 
with the microscopic description of calcification deposits 
on the larynx, trachea and bronchi. Later, Dalgaard and 
Moersch, Rokitansky and Luschka, described similar cases 
in 1856 and 1857 respectively, but without microscopic 
proof2,3. In 1896, von Schoroetter showed similar lesions 
in an indirect laryngoscopy. In 1910, Aschoff-Freiburg 
proposed the name osteoplastic tracheobronchopathy4. In 
the world literature it is estimated the existence of a few 
less than 400 cases already reported5,6.
The nodular injuries are sessile, calcified and vary in 
diameter between 1-10mm. They are characterized by slow 
and progressive growth, they can be localized or diffuse, 
covered by metaplastic epithelium or normal, emerging 
from the perichondrium and involving all the way to the 
lumen of the trachea, following the route of the tracheal 
rings, with active hematopoietic inclusion in nodular 
neoformation. It may cause stenosis in the laryngotrache-
obronchial lumen, without involving its posterior wall, 
with the possibility of progressing to the main bronchi7.
MATERIALS AND METHODS
In this paper we report 02 (two) cases in a descrip-
tive observational study. All the procedures for this study 
were previously authorized by the Ethics in Research 
Committee of our Institution, under protocol # 181/09, on 
December 09, 2009.
CASE PRESENTATION
Case 1
Patient M.R.F., female, 41 years of age, complaining 
of intermittent dysphonia for 15 years caused by vocal 
strain. In 1998 she started having dyspnea at medium 
physical stress and, in another service, she was submitted 
to bronchoscopy with local biopsy, showing: “bronchial 
mucosa with injuries mimicking papillomatosis, located on 
the trachea, carina and main bronchi, with the presence 
of mild edema and unspecific inflammatory reaction “. In 
the year 2000, since her dysphonia and stress dyspnea 
remained, she came to our ward and her ENT exam was 
normal.
Upon naso-laryngo-tracheo bronchoscopy through 
fiber optics, she had diffuse nodular injuries on the trachea 
wall, on the subglottic region all the way to the carina, with 
a 60% reduction in the trachea lumen, without involving 
the posterior region (Figures 1 and 2). Upon spirometry 
she had mild obstructive ventilatory disorder. Her chest CT 
showed a thickening on the tracheal wall, with irregular 
nodular injuries and reduction of the tracheal lumen. In 
2001, she had one episode of bronchopneumonia success-
fully treated with medication. In 2003, a new bronchoscopy 
with biopsy was carried out in order to diagnose OT (Fig. 
3). Today, the patient is stable, without worsening in her 
clinical presentation, undergoing clinical follow up.
Figure 1. Fibro-laryngo-tracheo-bronchoscopy: subglottis, showing 
multiple and diffuse nodular lesions, with free vocal folds.
Case 2
Patient A.D.B.F.C., female, 66 years old, with a 
history of nasal obstruction, progressive cough, hawk, 
night-time snoring, noisy breathing, dysphonia for 20 ye-
ars. In 2002, she started having chest pain and occasional 
dyspnea, and a bronchoscopy she underwent showed 
“polypoid tumors on the anterior and lateral trachea wall 
all the way to the carina”. Biopsy showed a mild lymph-
nuclear reaction on the submucosa, with a hyaline thicke-
ning of the basal membrane. OT was diagnosed and she 
was negative for amyloidosis.
Upon naso-laryngo-trachea bronchoscopy through 
fibroscopy, she had vocal fold edema and small trachea 
nodular lesions all the way to the carina. In April of 2003, 
she reports her dyspnea became more frequent, and a 
new exam showed nodular lesions in the trachea all the 
way to the carina, with mild lumen reduction and a chest 
CT scan showing thickening of the tracheal wall, with 
irregular nodular lesions and tracheal lumen narrowing. 
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Today, the patient is stable, without worsening in the 
clinical presentation described above, only undergoing 
annual clinical follow up (Fig. 4).
DISCUSSÃO
Osteochondroplastic tracheobronchopathy (OT) is 
a rare and benign disease, of unknown cause. It was ma-
croscopically described by Rokitansk in 1855 and micros-
copically described by Wilks in 1857. Some etiopathogeny 
theories have been postulated: Dalgaard (1947) - states that 
the elastic tissue suffers a metaplasia, with cartilage forma-
tion and calcium deposition; Virchow (1863) - echondrosis 
and exostosis promote calcium deposition and ossification 
of the tracheal rings; Aschoff-Freiburg (1910) - reports 
changes to the tracheal elastic tissue, introducing the term 
osteoplastic tracheopathy and, in 1964, Secrest et al. label 
it osteoplastic tracheobronchopathy8.
Its estimated clinical incidence varies between 
2-7:1,000; presenting between 25 and 85 years of age; and 
the 5th decade of life is the one most frequently affected. 
There is no gender predominance. The interval between 
the first symptoms and the diagnosis is about 4 years in 
45% of the cases; however, it may happen after 25 ye-
ars7. Incidental bronchoscopy findings happen to around 
3:2,000-5,000. According to Secrest, it is estimated that only 
5% of the cases are diagnosed during the person’s life9.
There is no correlation with smoking, however, 
some studies point to an association with chronic tracheal 
inflammatory processes, arguing that it can be a possible 
factor associated with disease progression9,10.
Its etiology and pathogenesis are unknown; ho-
wever, it is believed that chronic infection, congenital 
anomalies, chemical or mechanical irritation, degenera-
tive and metabolic disorders, chronic inflammation and 
the final stage of primary amyloidosis. Changes to the 
airway clearance help in disease onset after the persistent 
inflammatory process, resulting in repetitive infections. 
Bacteria such as Klebsiella ozenae or Botryomicosis have 
been shown in OT cases after chronic infection; however 
without an established correlation8,11.
Clinically, 13-50% of the patients may remain asymp-
tomatic. There are no pathognomonic characteristics for 
OT, with frequent possibilities of diagnostic mistakes and 
Figure 2. Fibro-laryngo-tracheo-bronchoscopy: showing the carina 
with nodular lesions, without involvement of the posterior tracheal wall.
Figure 3. Histology slide: ossification plaques on the respiratory 
mucosa corion.
Figure 4. Tracheal CT scan showing osteocartilaginous nodular lesions 
(arrows).
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initial treatment for asthma or bronchitis, as in the cases 
reported. There was cough in 66% of the cases, hemoptoic 
cough in 60%, dyspnea in 53% and panting in 30%. The 
pulmonary function test is usually normal - depending on 
the degree of stenosis12,13.
Chest X-Ray does not properly show the lesions, 
and CT scan is the image exam which best shows tracheal 
changes. On chest and trachea CT scans we can see the 
most common image changes: a few or numerous gross 
nodular lesions, of bony and/or cartilaginous (01-10mm) 
consistency, sessile and covered by an apparently normal 
mucosa of the trachea wall. Definitive diagnosis is con-
firmed through biopsy during fibro-naso-laryngotracheo-
bronchoscopy14. In our cases we ordered chest CT scans, 
which showed lesions similar to the ones found in the 
literature.
It frequently involves the lateral and anterior walls 
of the distal ¾ of the trachea, progressing to both main 
bronchi. Its anatomical distribution happens in 42% of 
the trachea, 6% in the bronchi and 52% in both. There 
are only a handful of reports of laryngeal and subglottic 
involvement9,11,15. In one of the cases the lesions progressed 
from the subglottis and trachea to the carina. In the other, 
the lesions involved the lower third of the tracheal all the 
way to the carina.
Histologically, the mucosal bed may look normal, 
with areas of inflammation and necrosis, abnormal prolife-
rative cartilaginous or bony formations on the submucosa; 
there may be squamous metaplasia of the columnar epithe-
lium, calcium deposits, fragments of adipocytes, with active 
hematopoietic medullar bone tissue10,11. In 2001, Leske et 
al. reported that in 40 biopsies they found the following 
changes: ossification (58%), squamous metaplasia of the 
respiratory epithelium (48%), cartilage (38%), calcification 
(20%) and amyloidosis 13%6,8,14.
There are no markers for OT. The C - reactive 
protein (CRP) and ESR may be altered because of the 
inflammatory processes. Calcium is normal and there are 
changes in the growth hormone and hyperphosphatemia, 
but it is likely a coincidence9. In 1996, Yokoyama et al. 
found an association with pulmonary cancer between 
11-19%, and adenocarcinoma was the most common 
histological type5,12.
In 1998, Zamani et al. found an elongated short arm 
of chromosome Y upon cytogenetic studies. Recent immu-
nohistochemistry studies argue that the bone morphoge-
netic protein 2 (BMP-2), in high concentrations increase 
the expression of b-1 transformation growth factor (TGF 
B-1) messenger RNA (mRNA), stimulates the production 
of extracellular matrix proteins for chondrocytes and bone 
neoformation. In the normal tissue of the tracheobronchial 
tree the BMP-2 protein is not present6,16. In our cases, TGF 
b-1 was detected in the chondrocytes and osteocytes of 
the submucosal nodules.
Among the differential diagnosis we find, mainly, 
papillomatosis, sarcoidosis, chondrosarcoma, hamartoma, 
amyloidosis, tuberculoid calcifications, dermatomyosites, 
scleroderma, Wegener’s disease, sarcoidosis and calcified 
paratracheal lymph nodes4,7,12,13.
The most common complications are: atelectasis 
and pneumonias1,7.
There is no specific treatment for OT, and it is rarely 
necessary. In a series study carried out in 2001, Lazor et 
al. noticed that in 55% of the cases there was no disease 
progression9. Antibiotics are used to treat the recurrent 
infections of the respiratory tract. Surgery is indicated when 
the symptoms no longer respond to clinical treatment - 
tracheal segment resection, anterior laryngo-cleft, partial 
laryngectomy, bronchoscopic removal of the lesions. 
Nd:YAG laser photocoagulation and also the placement 
of a silicone mold can be attempted15,17,18,19. Occasionally, 
tracheostomy is necessary. Prognosis is favorable and 
depends on the extension and location of the nodular 
lesions8-10,13. In the cases hereby reported we decided to 
follow up the patients annually in the clinic.
FINAL REMARKS
Osteochondroplastic tracheobronchopathy is a dise-
ase of unknown cause, where there is heterotopic ossifi-
cation of the laryngotracheobronchial cartilage, producing 
symptoms directly associated with the site and degree of 
upper airway obstruction. Frequent treatment is unneces-
sary, and usually clinical control is carried out when the 
patient is asymptomatic or has mild symptoms. Surgical 
removal is restricted to moderate to severe obstructions. 
ENT physicians must be attentive and include OT in their 
list of differential diagnosis when facing symptoms sug-
gesting upper airway and tracheal-bronchial tract.
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